Akers Biosciences, Inc. (AKER) Starts Presentation at LD Micro Invitational Conference

Akers Biosciences (NASDAQ: AKER) was founded in 1989 with the objective of developing proprietary, in vitro diagnostic technologies that accelerate the rate at which clinicians, and in some cases consumers, can obtain health information. The tests and sample preparation devices that emerge from the company’s rapid technology platforms are designed to provide the same level of accuracy as traditional laboratory testing methods, but at a fraction of the cost and turn-around time. Akers Biosciences is dedicated to the development of time- and cost-efficient, single-use devices that can be utilized almost anytime, anywhere. For more information, visit the company’s website at www.akersbio.com.